Zimmer Biomet

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products.

CEO

Ivan Tornos

CEOIvan Tornos

Employees

17,000

Employees17,000

Headquarters

Warsaw, Indiana

HeadquartersWarsaw, Indiana

Founded

1927

Founded1927

Employees

17,000

Employees17,000

ZBH Key Statistics

Market cap

16.13B

Market cap16.13B

Price-Earnings ratio

20.66

Price-Earnings ratio20.66

Dividend yield

1.21%

Dividend yield1.21%

Average volume

3.44M

Average volume3.44M

High today

$83.85

High today$83.85

Low today

$80.31

Low today$80.31

Open price

$81.14

Open price$81.14

Volume

2.44M

Volume2.44M

52 Week high

$108.29

52 Week high$108.29

52 Week low

$79.12

52 Week low$79.12

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $82.00, with a market capitalization of 16.13B. The stock trades at a price-to-earnings (P/E) ratio of 20.66 and offers a dividend yield of 1.2%.

On 2026-05-12, Zimmer Biomet(ZBH) stock moved within a range of $80.31 to $83.85. With shares now at $82.00, the stock is trading +2.1% above its intraday low and -2.2% below the session's peak.

Trading activity shows a volume of 2.44M, compared to an average daily volume of 3.44M.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

ZBH News

TipRanks 13h

Zimmer Biomet Expands 2026 Share Repurchase Program

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 13h

Zimmer Biomet increases share repurchase program by $250M

Zimmer Biomet (ZBH) announced that it now anticipates repurchasing up to $1B of its common stock during fiscal year 2026, a $250M increase from the company’s pr...

Simply Wall St 2d

Reaffirmed Guidance and CFO Exit Might Change The Case For Investing In Zimmer Biomet

Zimmer Biomet Holdings reported past first-quarter 2026 results with sales of US$2,086.7 million and net income of US$238.1 million, reaffirming its full-year r...

Analyst ratings

61%

of 31 ratings

Buy

29%

Hold

61.3%

Sell

9.7%

More ZBH News

Simply Wall St 4d

A Look At Zimmer Biomet Valuation After Strong Q1 2026 Results And CFO Transition

Advertisement Why Zimmer Biomet’s latest earnings and leadership changes matter for investors Zimmer Biomet Holdings (ZBH) has been in focus after Q1 2026 res...

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.